Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report) today and set a ...

In a report released yesterday, Vijay Rakesh from Mizuho Securities reiterated a Buy rating on Credo Technology Group Holding Ltd (CRDO – ...

Humana Inc. (the "company") (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate ...

PENN Entertainment (NASDAQ:PENN – Free Report) had its price objective raised by Mizuho from $24.00 to $25.00 in a research ...

Shares of Sunnova Energy International Inc. (NOVA) fell more than 3% during after-market trade on Tuesday after analysts at ...

State Street Corporation (NYSE: STT) and Mizuho Financial Group, Inc. (President & Group CEO: Masahiro Kihara) today ...

Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior ...

Hubbell Incorporated (NYSE:HUBB – Get Free Report) was the target of a large growth in short interest in February. As of February 15th, there was short interest totalling 2,040,000 shares, a growth of ...

Mizuho (NYSE:MFG) Securities USA LLC, a significant stakeholder in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK), has recently sold a substantial portion of its holdings in the company.

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...